Neuromuscular Blocking Agents in Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

May 10, 2025

Study Completion Date

May 15, 2025

Conditions
Cardiac SurgeryNeuromuscular Blocking Agents
Interventions
DIAGNOSTIC_TEST

Neuromuscular blockade

Neuromuscular blockade will be measured in all patients using a quantitative measurement (TOFScan, IdMed, Marseille, France) during surgery and after surgery until either full neuromuscular recovery or time of scheduled extubation.

Trial Locations (1)

1070

H.U.B - Hôpital Erasme, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT06595277 - Neuromuscular Blocking Agents in Cardiac Surgery | Biotech Hunter | Biotech Hunter